by Nicola Magrini, Jane Robertson, Gilles Forte et al.
Bulletin of the World Health Organization – Published online: 12 March 2015
In 1977, the World Health Organization published its first Model List of Essential Medicines. This year, the Expert Committee for the Selection and Use of Medicines will consider requests to include high-cost medicines for cancer, hepatitis C, multidrug-resistant tuberculosis and new oral anticoagulants on the Model List. These applications challenge perceptions of essential medicines and raise questions about how to address issues of cost and affordability for countries when making decisions at the global level.